Transcatheter Aortic Valve Implantation for Degenerated 19-mm Aortic Bioprosthetic Valve

Kizuku Yamashita; Tomoyuki Fujita; Satsuki Fukushima; Yusuke Shimahara; Yuta Kume; Yorihiko Matsumoto; Naonori Kawamoto; Tatsuro Hitsumoto; Nobuyasu Ito; Yasuhiro Hamatani; Atsushi Okada; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Yasuo Sugano; Hideaki Kanzaki; Toshihisa Anzai; Satoshi Yasuda; Junjiro Kobayashi

doi:10.1253/circj.CJ-17-0851

This article has now been updated. Please use the final version.

Transcatheter Aortic Valve Implantation for Degenerated 19-mm Aortic Bioprosthetic Valve

Kizuku Yamashita, Tomoyuki Fujita, Satsuki Fukushima, Yusuke Shimahara, Yuta Kume, Yorihiko Matsumoto, Naonori Kawamoto, Tatsuro Hitsumoto, Nobuyasu Ito, Yasuhiro Hamatani, Atsushi Okada, Hiroyuki Takahama, Makoto Amaki, Takuya Hasegawa, Yasuo Sugano, Hideaki Kanzaki, Toshihisa Anzai, Satoshi Yasuda, Junjiro Kobayashi

Author information

Kizuku Yamashita
Department of Cardiac Surgery, National Cerebral and Cardiovascular Center
Tomoyuki Fujita
Department of Cardiac Surgery, National Cerebral and Cardiovascular Center
Satsuki Fukushima
Department of Cardiac Surgery, National Cerebral and Cardiovascular Center
Yusuke Shimahara
Department of Cardiac Surgery, National Cerebral and Cardiovascular Center
Yuta Kume
Department of Cardiac Surgery, National Cerebral and Cardiovascular Center
Yorihiko Matsumoto
Department of Cardiac Surgery, National Cerebral and Cardiovascular Center
Naonori Kawamoto
Department of Cardiac Surgery, National Cerebral and Cardiovascular Center
Tatsuro Hitsumoto
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Nobuyasu Ito
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Yasuhiro Hamatani
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Atsushi Okada
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Hiroyuki Takahama
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Makoto Amaki
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Takuya Hasegawa
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Yasuo Sugano
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Hideaki Kanzaki
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Toshihisa Anzai
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Satoshi Yasuda
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Junjiro Kobayashi
Department of Cardiac Surgery, National Cerebral and Cardiovascular Center

Keywords: Degenerated bioprosthesis, Transcatheter aortic valve implantation, Valve-in-valve

JOURNAL FREE ACCESS FULL-TEXT HTML Advance online publication

Article ID: CJ-17-0851

DOI https://doi.org/10.1253/circj.CJ-17-0851

The final version of this article is now available: Vol. 82 (2017), No. 1 pp. 289-292

Details

Abstract

Background:The valve-in-valve procedure, in which a transcatheter heart valve (THV) is implanted over a prosthetic valve, has been shown to be safe and therapeutically effective, depending on the size of the replacement valve.

Methods and Results:We report 3 cases of successful valve-in-valve procedure to replace a degenerated 19-mm stented prosthetic aortic valve. Balloon-expanding THVs were implanted: 20-mm in the 1st case and 23-mm in the next 2. Aortic stenosis was almost completely resolved in all patients, who recovered promptly and without cardiac adverse events.

Conclusions:Using the valve-in-valve procedure for a 19-mm degenerated bioprosthesis was feasible and safe.

Corresponding author

Register with J-STAGE for free!